样式: 排序: IF: - GO 导出 标记为已读
-
Mapping multimorbidity from diabetes mellitus and its association with depressive symptoms among older people of India: a cross-sectional study from a nationally representative survey Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-03-14 Gayatri Khanal, Y. Selvamani, J. Kezia Angeline
Background India is the second major epicenter of diabetes mellitus (DM) prevalence after China and predicted to overtake China by 2045. DM is associated with multimorbidity which has tremendous impact on mental health. However, little is known about patterns of morbidities and their associations with depression. Objective The purpose of this article is to ascertain multimorbidity in the DM population
-
Cardiovascular autonomic neuropathy and charcot neuroarthropathy in type 2 diabetes: adding a new severity classification score Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-03-11 Jessica Castro de Vasconcelos, Yeelen Ballesteros Atala, Denise Engelbrecht Zantut-Wittmann, Maria Cândida Ribeiro Parisi
Objective This study aimed to assess the presence and characteristics of cardiovascular autonomic neuropathy (CAN) in people with type 2 diabetes with and without Charcot neuroarthropathy (CN). Background Diabetes can affect nerves in many ways beyond sensitive neuropathy. Methods A cross-sectional study was carried out in people with diabetes and CN who were matched for sex and age with two groups
-
Self reported hypoglycemia in patients with type 2 diabetes mellitus taking oral anti-diabetics Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-03-09 Mahak Golani, Sanjay Pandit, Sumeet Singla
-
Cluster analysis based on fasting and postprandial plasma glucose and insulin concentrations Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-03-07 Miguel Altuve, Erika Severeyn
Objective Plasma glucose and insulin concentrations are clinical markers used to diagnose metabolic diseases, particularly prediabetes and diabetes. In this paper, we conducted a cluster analysis using plasma glucose and insulin data collected during both fasting and 2-h postprandial periods. Methods Different clustering experiments were performed by changing the attributes, from one (fasting glucose)
-
The relationship between glycated hemoglobin (HbA1c), hematocrit, mean platelet volume, total white blood cell counts, Visceral Adiposity Index, and Systematic Coronary Risk Evaluation 2 (SCORE2) in patients without diabetes Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-03-07 Cem Yesiloglu, Canan Emiroglu, Cenk Aypak
Objective Cardiovascular diseases (CVD) are the most common, deadly, noncommunicable disease group globally. This study aims to investigate the relationship between Systematic Coronary Risk Evaluation 2 (SCORE2) scores, which indicate the risk of future CVD in patients without known CVD and diabetes mellitus (DM) diagnoses, and HbA1c values. Methods In our retrospective cross-sectional study, patients
-
Effect of rosuvastatin on sortilin and fetuin-A in type 2 diabetic patients: a randomized controlled trial Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-03-02
Abstract Objective Rosuvastatin is a drug used for decreasing the risk of cardiovascular complications in type 2 diabetes mellitus (T2DM) patients. It is hypothesized that fetuin-A encourages lipid-induced insulin resistance and sortilin may increase the risk of atherosclerotic-related disorders. The aim of this study is to investigate the safety and efficacy of rosuvastatin co-treatment in T2DM patients
-
Decoding the mystery of non-nutritive sweeteners Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-02-24 Sachdev Meenakshi, Viswanathan Mohan
Background This commentary explores the landscape of non-nutritive sweeteners, further delves into the historical trajectory and the contemporary surge in the consumption of non-nutritive sweeteners (NNS), along with the accompanying controversies concerning their safety. Objective The aim is to provide a comprehensive understanding of the influences of NNS, drawn from global studies and diverse perspectives
-
Examining risk factors for diabetic foot: assessing diabetes self-management in type 2 diabetes patients Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-02-22 Veysel Ürekli, Egemen Tural, Akın Dayan
Objective Poor sugar regulation heightens the risk of complications linked to type 2 diabetes mellitus, while the adoption of effective diabetes self-management strategies has been shown to mitigate these risks. The objective of the study was to investigate the risk factors for diabetic foot by evaluating diabetes self-management using the Diabetes Self-Management Scale in patients with type 2 diabetes
-
Corneal endothelial morphology changes in patients with proliferative diabetic retinopathy Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-02-17 Xiaoli Yu, Xiaojuan Chen, Lele Li, Min Wang, Lidan Xue, Yue Zhou, Lili Huang
Background Diabetes patients often suffer from diabetes keratopathy in the course of their illness. The examination of corneal endothelium in proliferative diabetic retinopathy (PDR) patients has important clinical significance. Here, we investigated the effect of PDR on corneal endothelial parameters. Objective To analyze the associations between corneal endothelial cell parameters and proliferative
-
A randomized, double-blind, active-controlled trial assessing the efficacy and safety of a fixed-dose combination (FDC) of MEtformin hydrochloride 1000 mg ER, SItagliptin phosphate 100 mg, and DApagliflozin propanediol 10 mg in Indian adults with type 2 diabetes: The MESIDA trial Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-02-17
Abstract Objective To assess the efficacy and safety of fixed-dose combinations (FDC) of triple-drug dapagliflozin, sitagliptin, and metformin (DSM) compared with FDC of two-drug sitagliptin and metformin (SM), in Indian adult patients with type 2 diabetes (T2D). Methods A multicentric, randomized, double-blind, active-controlled, Phase 3 study (CTRI/2021/10/037461) was conducted on 274 Indian adult
-
Impacts of a 12-week aerobic, resistance, and combined exercise training on serum FAM19A5, glucose homeostasis, and novel cardiovascular risk factors among adults with obesity Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-02-07 Ehsan Mir, Alireza Shamseddini, Najmeh Rahimi, Behzad Bazgir
-
The HNF1B mutations and deletion associated with diabetes and their resulting diabetic phenotypes: a systematic review Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-02-07
Abstract Objective Mutations or deletion in HNF1B gene has been found to be related to a special type of monogenetic diabetes (HNF1B-DM). However, the phenotypic features of HNF1B-DM and the related gene abnormalities remain unclear. Methods We systemically reviewed the literature associated with HNF1B-DM in PubMed, China National Knowledge Infrastructure (CNKI), and Wanfang databases. The mutations
-
Effectiveness and safety of insulin glargine U-300 as compared to insulin glargine U-100 in oral antidiabetic (OAD) failure cases—record-based observational study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-02-07 Shambo S. Samajdar, Shashank R. Joshi, Sougata Sarkar, Santanu K. Tripathi, Satyabrata Sahoo, Nandini Chatterjee, Jyotirmoy Pal, Rutul A. Gokalani
-
24-h Glucose profile of patients with gestational diabetes mellitus and comparison with pregnant women with normoglycemia Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-29
Abstract Objective To study the 24-h glucose profile of patients with mild GDM using the commercially available Abbot Libre continuous glucose monitoring system (CGMS) and compare them with pregnant women with normoglycemia (gestational age comparable). Methods A case control study conducted between 2019-2020 followed eligible pregnant women diagnosed with GDM according to Diabetes in Pregnancy Study
-
Predictive value of Lp-PLA2 for coronary artery disease in type 2 diabetes mellitus patients: an observational study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-24
Abstract Objective Type 2 diabetes mellitus (T2DM) is a chronic disease characterized by elevated blood glucose levels, which can result in a variety of complications, including coronary artery disease (CAD). Lp-PLA2 is a proinflammatory enzyme associated with low-density lipoprotein (LDL) particles in the circulation and is thought to be a biomarker for CAD risk. Methods The purpose of this investigation
-
Biomarkers of endothelial dysfunction (vWF), hypofibrinolysis (PAI-1) and metabolic syndrome components in hypertensive patients with and without thrombotic complications Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-22 David Santiago-Germán, Rosa María Jiménez-Alvarado, Alfredo Leaños-Miranda, Irma Isordia-Salas
-
Diabetic retinopathy screening guidelines for Physicians in India: position statement by the Research Society for the Study of Diabetes in India (RSSDI) and the Vitreoretinal Society of India (VRSI)-2023 Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-20 Manisha Agarwal, Padmaja Kumari Rani, Rajiv Raman, Raja Narayanan, Sreenivasamurthy L., Anil Virmani, Ramachandan Rajalakshmi, Sudha Chandrashekhar, Brij Mohan Makkar, Sanjay Agarwal, Mahesh Shanmugam Palanivelu, Muralidhar Naveenam Srinivasa, Kim Ramasamy
-
Factors affecting the prolongation of glycemic time in range among children with type 1 diabetes using continuous glucose monitoring systems: A case control study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-19 Kowalczyk-Korcz Emilia, Szypowska Agnieszka
-
Iranian patients with diabetes and COVID-19-associated mucormycosis: Characteristics, manifestations, and mortality risk factors Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-18 Mohammadreza Salehi, Alireza Esteghamati, Sadegh Khodavaisy, Nasim Khajavi Rad, Alireza Abdollahi, Sayyed Amirsina Alemzadeh, Sadaf Nasserisina, Azin Tabari, Farzad Pakdel, Saeed Mohammadi, Neda Joorabloo, Mahsa Abdorahimi, Mehrdad Shavandi, Soghra Rabizadeh
Objective This study evaluated the mortality risk factors in Iranian patients with diabetes mellitus (DM) and COVID-19-associated mucormycosis (CAM). Methods This retrospective study was conducted on confirmed CAM cases with DM. Only patients with a confirmed history of COVID-19 within the last 3 months were included. The patients were divided into the survived and deceased groups, and each group’s
-
Relationship between impaired sensitivity to thyroid hormones and MAFLD with elevated liver enzymes in the euthyroid population Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-09
Abstract Objective There is a delicate interplay between thyroid hormones and thyrotropin (TSH) and metabolic homeostasis. However, the role of thyroid hormone sensitivity in metabolic health, particularly in relation to metabolic dysfunction-associated fatty liver disease (MAFLD) and associated complications such as elevated liver enzymes and free fatty acid (FFAs) has not been elucidated in euthyroid
-
Assessment of equations estimating average glucose among patients with diabetic kidney disease before dialysis Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-08 Yi Lu, Xiangyu Wang, Qian Zhang, Yaoming Xue
-
The value of contrast-enhanced ultrasound in the diagnosis of microcirculatory perfusion abnormalities in diabetic foot Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-05 Lan-fang He, Hua-ying Yan, Yi Yuan, Jia Kang, De Lv, Yu Kang
-
Cytokine gene polymorphism with type 2 diabetes and diabetic nephropathy in population from West India Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-03 Brijesh K. Dabhi, Kinnari N. Mistry, Jinal M. Thakor, Sishir Gang
Objective Genetic polymorphisms of the angiogenesis, inflammatory cascade, or apoptosis genes can influence chronic complications in diabetic patients. Cytokine gene polymorphisms are considered vital in diabetes and diabetic nephropathy (DN) susceptibility. The present study evaluated the role of cytokine gene polymorphism in type 2 diabetes and diabetic nephropathy. Methods A total number of 648
-
The effects of sodium-glucose cotransporters type 2 inhibitors on glycemic and extraglycemic laboratory parameters Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2024-01-03 Deniz Yilmaz, Ezgi Sahin, Fatma Akyol, Bahar Guler Filiz, Elif Ezirmik
Background An ideal glucose-lowering drug is expected to not only improve glycemic control, but also have positive effects on weight, blood pressure, dyslipidemia, and also cardiovascular and renal outcomes. Objective To investigate and compare the impact of Sodium-glucose transport protein 2 (SGLT2) inhibitors on glycemic and extraglycemic laboratory parameters and the parameters which affect this
-
Clinical risk factors analysis and prevention of osteoporosis as a complication of diabetes Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-12-27
Abstract Objective Osteoporosis is a common complication of type 2 diabetes. This study aimed to provide a basis for the clinical prevention and treatment of osteoporosis as a complication of type 2 diabetes. Methods We retrospectively analyzed patients hospitalized with type 2 diabetes with or without osteoporosis. Binary logistic regression was performed to assess the relationship between the assessed
-
Parental monitoring status of the children with type 1 diabetes mellitus (DM) and their quality of life Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-12-27 Esra Tural Buyuk, Hatice Uzsen, Merve Koyun, Reyhan Dönertaş
Objective This study was carried out to determine the relationship between parental monitoring status of the children with type 1 DM and their quality of life. Methods This descriptive-correlational type study was conducted in the pediatric endocrine outpatient clinic of a university hospital located in the northern region of Turkey and included 126 children with type 1 diabetes. The data of the study
-
Poor accuracy of HbA1c for the diagnosis of prediabetes in overweight and obese Bangladeshi adults Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-12-27 Tahniyah Haq, Md. Fariduddin, Md Abul Hasanat, Nishat Nayla Aurpa, Md. Sohel Rana Bhuiyan, Afia Zainab Tanni
-
Clinical reflections of diabetic nephropathy related pathological lesions Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-12-26 Ali Can Kurtipek, Şimal Köksal Cevher, Ezgi Coşkun Yenigün, Aysel Çolak, Cenk Aypak, Selma Karaahmetoğlu
Background The Renal Pathology Society developed a universal pathological classification of diabetic nephropathy in 2010. Some research has been conducted to validate this classification’s ability to predict the outcome. However, the clinical implications of these pathological abnormalities are still being investigated. Objectives In this study, we aimed to demonstrate the clinical reflections of these
-
A retrospective electronic medical record-based study of insulin usage and outcomes in insulin-naive Indian adults with T2DM: The REALITY study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-12-15 M. Chawla, B. M. Makkar, K. D. Modi, S. Phatak, S. Waghdhare, A. Satpathy, A. Gadekar, D. Chodankar, C. Trivedi, K. M. Prasanna Kumar, V. Mohan
-
Association between nesfatin-1 hormone levels, anthropometric measurements, and glucose regulation shortly after sleeve gastrectomy: A cross-sectional study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-12-11 Ayşegül Sivaslıoğlu, Hakan Buluş, Doğan Öztürk, Evrim Kahramanoğlu Aksoy, Zeynep Göktaş
Objective This cross-sectional study was planned to evaluate the relationship between serum nesfatin-1 levels, glucose regulation and anthropometric measurements of individuals who had undergone sleeve gastrectomy. Methods A total of 40 participants aged between 19 and 64 years with a body mass index (BMI) greater than 30 kg/m2 who underwent sleeve gastrectomy participated in the study. Before and
-
High expression of the glutathione S-transferase A2 and neuropilin-2 genes affects pancreatic islet β-cell function Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-12-06 Jiarui Zhang, Wenzhe Wu, Lichenlu Huang, Yongqin Zheng, Yikun Zhou, Jundong He
-
Effect of aerobic training on baroreflex sensitivity, heart rate recovery, and heart rate variability in type 2 diabetes: a systematic review Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-28 Sarah Parveen, Muhammad Azharuddin, Majumi M. Noohu
-
Prevalence and associated factors of tenia pedis among patients with diabetes in Jordan Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-27 Anas Ababneh, Hesham Alrauosh, Mousa Abujbara, Hashem Kanaan, Faris G. Bakri, Nidal A. Younes
Background Diabetes mellitus is an etiological factor of tinea pedis (TP) which can increase the risk of diabetes-related foot complications. There is scarce research investigating the epidemiology of TP among patients with diabetes and this study contributed to filling this gap. Objective To identify the prevalence and the associated factors of TP among patients with diabetes in Jordan. Methods A
-
Expression of NLRP3 and superoxide dismutase-2 (SOD2) in the gingival tissues of periodontitis patients with and without type 2 diabetes mellitus: a case–control study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-27 Gayathri Varadharajulu, Dhayanand John Victor, Santhosh Venkadassalapathy, Devapriya Appukuttan, P. S. G. Prakash, Sangeetha Subramanian
-
Fasting plasma glucose and 2-h postprandial plasma glucose characteristics in a large multi-ethnic Chinese population Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-25 Xiaohan Xu, Duolao Wang, Shabbar Jaffar, Uazman Alam, Shanhu Qiu, Bo Xie, Zilin Sun, Anupam Garrib
-
Insulin titration and blood glucose fluctuations during pregnancy in GCK-MODY: Case Report Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-20 Yilin Zhao, Tianhao Ba, Qian Ren, Xueyao Han, Linong Ji
-
Influence of cerebral small vessel disease on functional outcome and recurrence of cerebral infarction in patients with type 2 diabetes Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-21 Huiwei XU, Song ZHANG, Juan XU, Binbin YUAN, Huangcheng SONG
-
Correlation of presence and severity of glucose derangements with severity of Liver Cirrhosis: a hospital-based cross sectional observational study from New Delhi Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-22 Prashasti Gupta, Aparna Agrawal, Jayashree Bhattacharjee
Background Association between liver cirrhosis (LC) and glucose intolerance has been known since long. Many studies in the past have attempted to explore the correlation of glucose metabolism disorders (GMD) with the severity of LC with mixed results (some favouring i.e. higher prevalence of GMD in more severe LC; others negating). This study was conducted to shed further light on the significance
-
Association of the rs7903146 variant (IVS3C> T) of TCF7L2 with the prevalence of the metabolic syndrome and its components in population from Ahvaz cohort study: a case-control study in Iran Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-20 Mojdeh Rahimi, Negar dinarvand, Hajieh Shahbazian, Maryam Tahmasebi Birgani, Bahman cheraghian, Narges Mohammadtaghvaei
Background The metabolic syndrome consists of a combination of metabolic abnormalities and genetic predisposition that both contribute significantly to its development. Numerous studies have established a strong association between single nucleotide polymorphisms (SNPs) of the rs7903146 variant in the TCF7L2 gene and the metabolic syndrome (MetS) as well as type 2 diabetes. Objective The aim of this
-
Differences in nutrition, handgrip strength, and quality of life in patients with and without diabetes on maintenance hemodialysis in Xi’an of China Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-20 Lu Zhang, Sumei Zhang, Shengyan Shi, Haiying Quan, Xiu Yang, Xuanbin Tang
Objective Malnutrition, reduced muscle function, and reduced quality of life are common problems among patients undergoing maintenance hemodialysis (MHD). This study aimed to evaluate nutritional risk, handgrip strength, and quality of life between patients with and without diabetes undergoing MHD to improve the nutrition, handgrip strength, and quality of life of patients with diabetic. Methods This
-
Modeling of postprandial glycemic response by consecutive reaction kinetics model for precise glycemic control Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-17 Cheng Li
-
The effect of prediabetes and diabetes on the incidence of cardiovascular disease in the population of 40 to 70 years in the south of Iran: a population-based cohort study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-14 Leila Moftakhar, Abbas Rezaianzadeh, Mozhgan Seif, Masoumeh Ghoddusi Johari, Seyed Vahid Hosseini
-
Association between dietary glycemic and insulin index/load and cardiometabolic risk factors among people with diabetes Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-14 Zahra Hassanzadeh-Rostami, Kimia Ghaedi, Seyed Jalil Masoumi
Objective Limited studies have been conducted on insulin index/load, with inconsistent results regarding the glycemic index/load in relation to cardiometabolic risk factors among people with diabetes. The present study aimed to reveal the association of dietary glycemic index and load and dietary insulin index and load with cardiometabolic risk factors among people with diabetes. Method This cross-sectional
-
The effect of dapagliflozin use on cardiovascular outcomes in type 2 diabetic patients hospitalized with COVID-19 Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-15 Ozlem Ozbek, Mehmet Mustafa Can
Objective We aimed to evaluate the impact of dapagliflozin on reducing major adverse cardiovascular events (MACE) and all-cause mortality in patients with COVID-19 and to assess whether it was associated with clinical improvement. Methods Between March 2020 and July 2022, 446 diabetic patients hospitalized with COVID-19 were included in the study and were divided into two groups in terms of dapagliflozin
-
Serum and urinary levels of tumor necrosis factor-alpha and interferon-gamma in diabetic nephropathy patients: a systematic review Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-13 Chastene Christopher Flake, Imoan Shallom Aguas, Archie Policarpio, Angelanna Ysais, Raphael Enrique Tiongco, Annalyn Navarro
-
Association of microRNA-192, pentraxin-3, and transforming growth factor-beta1 with estimated glomerular filtration rate in adults with diabetic nephropathy Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-08 Zienab R. Negeem, Adel Abdel Moneim, Basant Mahmoud, Amr E. Ahmed, Nabil A. Hasona
-
Surrogate markers of metabolic syndrome and insulin resistance in children and young adults with type 1 diabetes: a systematic review & meta-analysis (MetS and IR in T1DM) Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-06 Sukeshini B. Khandagale, Vinesh S. Kamble, Chirantap Oza, Shital Bhor, Anuradha V. Khadilkar, Satyajeet P. Khare
-
The association of HbA1C and cTnI with mortality and severity of disease among patients with acute coronary syndrome Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-11-02 Mahboobeh Sheikh, Pouya Ostadrahimi
-
Empagliflozin combined with short-term intensive insulin therapy improves glycemic variability and 1,5-anhydroglucitol in patients with type 2 diabetes: a randomized clinical trial Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-31 Zhihua Hao, Yuliang Zhao, Qiuxiao Zhu, Yanhong Ge, Zibo Liu, Yanxia Chen, Lijing Jiao, Xin Zhao, Xing Wang, Jing Wang, Jing Zhou, Huiyao Hao, Yongmei Hao, Hong Zhou, Mian Wang, Lihui Zhang
-
The influence of CDKAL1 (rs7754840) gene polymorphism on susceptibility to gestational diabetes mellitus in pregnant women: a systematic review and meta-analysis Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-31 Amir Hossein Mahdizade, Seyed Sobhan Bahreiny, Mohammad-Navid Bastani, Mohammad Reza Dabbagh, Mojtaba Aghaei, Fardin Ali Malayeri, Aryan YousefiFard, Eskandar Taghizadeh
-
Severe limited joint mobility (LJM) involving both the hands and feet in type 1 diabetes mellitus Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-28 Shinjan Patra, Ritika Biswas
-
Multivariable prediction model of complications derived from diabetes mellitus using machine learning on scarce highly unbalanced data Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-26 Claudia C. Colmenares-Mejía, Juan C. Rincón-Acuña, Andrés Cely, Abel E. González-Vélez, Andrea Castillo, Jossie Murcia, Mario A. Isaza-Ruget
-
Stepping up foot care: assessment over foot care knowledge and behavior among individuals with diabetes of risk levels Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-28 Mengwen Li, Mengyao Wei, Binru Han, Hongjuan Wu
Background Diabetic foot is a global threat to public health, as it can lead to infections and amputations and cause significant pain and economic costs for patients. Diabetic foot patients in northern China have more severe local ulcers, worse prognosis, and longer disease duration. Objective This study assessed the foot risk levels and foot care knowledge and behavior status of people with diabetes
-
Risk factors associated with severity, prognosis, and evolution of patients with tropical diabetic hand syndrome Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-28 Arnulfo A. Ríos-Cantú, Jorge A. Garza-Cerna, Hernán Chacón-Moreno, Yanko Castro-Govea, Everardo Valdés-Flores, Mauricio M. García-Pérez
-
Impact of the supplementation of melatonin on oxidative stress marker and serum endothelin-1 in patients with metabolic syndrome Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-28 Hossein Ghaderi-Zefrehi, Faezeh Seif, Reyhaneh Niayesh‐Mehr, Saleh Ayashi, Sima Jafarirad, Zahra Niknam, Mohammad Hessam Rafiee, Hossein Babaahmadi‐Rezaei
-
Inflammatory potential of the diet is associated with psychological stress in adults with type 2 diabetes: a methodological approach of e-Health Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-23 Abril I. Sánchez-Rosales, Laura S. Gaona-Valle, Ana L. Guadarrama-López, Beatriz E. Martínez-Carrillo, Roxana Valdés-Ramos
-
Effects of exercises and manual therapy on nerve conduction studies of lower limb in patients with diabetes and diabetic peripheral neuropathy: A systematic review Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-23 Jyoti Sharma, Irshad Ahmad, Arun Kumar Chandresh Singh
-
Effectiveness and safety of Glargine U-100 and detemir insulin in hyperglycemic pregnancy: a record-based observational study Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-23 Shambo S. Samajdar, Shashank R. Joshi, Shatavisa Mukherjee, Sougata Sarkar, Santanu K. Tripathi, Satyabrata Sahoo, Nandini Chatterjee, Jyotirmoy Pal, Rutul A. Gokalani
-
Prevalence of thyroid nodule and its association with β-cell autoantibodies in adult patients with type 1 diabetes mellitus without thyroid dysfunction Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-18 Murat Calapkulu, Muhammed Erkam Sencar, Davut Sakiz, Ilknur Ozturk Unsal, Merve Tekinyildiz, Hakan Düger, Mustafa Ozbek, Erman Cakal
-
Diagnosis of latent autoimmune diabetes after SARS–Cov2 vaccination in adult patients previously diagnosed with type 2 diabetes mellitus Int. J. Diabetes Dev. Ctries. (IF 0.9) Pub Date : 2023-10-13 Berna İmge Aydoğan, Uğur Ünlütürk, Mustafa Cesur
Objective Acute worsening of glycemic control in diabetic patients and new–onset type I diabetes were reported after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines. Latent autoimmune diabetes in adults (LADA) is defined as a slowly evolving immune–mediated diabetes. A few cases of LADA diagnosed after SARS-CoV-2 vaccination have been reported in the literature. This study aims